| 000 | 01233 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512005725.0 | ||
| 264 | 0 | _c19890823 | |
| 008 | 198908s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYanovich, S | |
| 245 | 0 | 0 |
_aCharacterization of a K562 multidrug-resistant cell line. _h[electronic resource] |
| 260 |
_bCancer research _cAug 1989 |
||
| 300 |
_a4499-503 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B, Member 1 |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDaunorubicin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDrug Resistance _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Erythroblastic, Acute _ximmunology |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xanalysis |
| 650 | 0 | 4 |
_aMembrane Proteins _xanalysis |
| 650 | 0 | 4 | _aMolecular Weight |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 700 | 1 | _aHall, R E | |
| 700 | 1 | _aGewirtz, D A | |
| 773 | 0 |
_tCancer research _gvol. 49 _gno. 16 _gp. 4499-503 |
|
| 999 |
_c2574113 _d2574113 |
||